Sleep-loss related to itch in atopic dermatitis: assessing content validity and psychometric properties of a patient-reported sleep-loss rating scale.

Autor: Rams A; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA., Baldasaro J; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA., Bunod L; Modus Outcomes, a Division of THREAD, Lyon, France., Delbecque L; Eli Lilly and Company, Indianapolis, IN, USA., Strzok S; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA., Meunier J; Modus Outcomes, a Division of THREAD, Lyon, France. juliette.meunier@modusoutcomes.com., ElMaraghy H; Eli Lilly and Company, Indianapolis, IN, USA., Sun L; Eli Lilly and Company, Indianapolis, IN, USA., Pierce E; Eli Lilly and Company, Indianapolis, IN, USA.

Publikováno v: Journal of patient-reported outcomes [J Patient Rep Outcomes] 2024 Jul 22; Vol. 8 (1), pp. 77. Date of Electronic Publication: 2024 Jul 22.

Development and Preliminary Validation of an Instrument to Measure Symptoms and Impacts in Patients with Proliferative Diabetic Retinopathy.

Autor: Rofail D; Regeneron Pharmaceuticals, Inc., 1 Rockwood Road, Sleepy Hollow, NY, 10591, USA. diana.rofail@regeneron.com., Sherman S; Regeneron Pharmaceuticals, Inc., 1 Rockwood Road, Sleepy Hollow, NY, 10591, USA., Hartford C; Regeneron Pharmaceuticals, Inc., 1 Rockwood Road, Sleepy Hollow, NY, 10591, USA., Levine A; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA.; Center for the Evaluation of Value and Risk in Health, Boston, MA, USA., Baldasaro J; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA., Marquis P; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA., Rao R; Regeneron Pharmaceuticals, Inc., 1 Rockwood Road, Sleepy Hollow, NY, 10591, USA., Do DV; Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.

Publikováno v: Advances in therapy [Adv Ther] 2023 Apr; Vol. 40 (4), pp. 1773-1786. Date of Electronic Publication: 2023 Feb 27.

PCR179 Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer (SCLC): A Qualitative Interview Study

Autor: Altman, D, Fu, AC, Marquis, P, Rams, A, Baldasaro, J, Ali, Ahmad S, Schlichting, M, Zhang, X

Publikováno v: In Value in Health July 2022 25(7) Supplement:S575-S575

"I Can't Take off My Shirt or Do My Own Hair"-A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP).

Autor: Markowitz JT; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA., Rofail D; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. diana.rofail@regeneron.com., Vandenberg G; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA., Baldasaro J; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA., Sanchez RJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Pignolo RJ; Mayo Clinic, Rochester, MN, USA., Keen R; Royal Orthopaedic Hospital, Stanmore, UK., Davis M; International Fibrodysplasia Ossificans Progressiva Association, North Kansas City, MO, USA., Marquis P; Modus Outcomes, a Division of THREAD, Cambridge, MA, USA.

Publikováno v: Advances in therapy [Adv Ther] 2022 Jun; Vol. 39 (6), pp. 2796-2805. Date of Electronic Publication: 2022 Apr 16.

Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study.

Autor: Gooderham, Melinda¹ (AUTHOR) mgooderham@centrefordermatology.com, Guttman-Yassky, Emma² (AUTHOR), Igawa, Ken³ (AUTHOR), Kabashima, Kenji⁴ (AUTHOR), Esfandiari, Ehsanollah⁵ (AUTHOR), Rylands, Angela J.⁵ (AUTHOR), Williams, Angela⁵ (AUTHOR), Nixon, Annabel⁶ (AUTHOR), Dent, Jennifer E.⁶ (AUTHOR), Simpson, Eric⁷ (AUTHOR)

Publikováno v: Dermatology & Therapy. Dec2024, Vol. 14 Issue 12, p3351-3366. 16p.